Seeking Alpha
0
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

Week In Review: WuXi NextCode Leads $15 Million Financing In Claritas Genomics

Deals and Financings

WuXi NextCODE Genomics, the newly formed genomic analysis division of China CRO/CMO WuXi PharmaTech (WX), led a $15 million Series B financing in Claritas Genomics (see story). Claritas is a Boston-based lab that develops and provides next-gen sequence-based tests for pediatric genomic disorders. The company was spun out of Boston Children's Hospital two years ago with assistance from Life Technologies (LIFE). WuXi NextCODE was formed earlier this year when WuXi PharmaTech paid $65 million to acquire NextCODE Health, a genomics sequencing company.

Armetheon, a San Francisco area specialty biopharma, raised $24.3 million in a Series B funding that will be used to underwrite a Phase III trial of its oral anticoagulant, tecarfarin (see story). Participants in the financing had Taiwan/China connections. The B round was co-led by Hercules Bioventure Partners and Capital TEN II, which are affiliated with Larry Hsu, Ph.D., a co-founder of Idenix… Read More …